Patient Content

As an experienced freelance medical writer and editor, I help healthcare organizations educate patient audiences about their conditions by using the principles of plain language.
iStock 931409422
Patient Content
DeLene Beeland

FDA Approves First Generic of Restasis

The U.S. Food and Drug Administration (FDA) has approved the first generic of Restasis© (cyclosporine ophthalmic emulsion) eye drops to increase tear production in people

iStock 1270933857
Patient Content
DeLene Beeland

What Is Cibinqo® (abrocitinib)?

Cibinqo® (abrocitinib) is a daily medicine for moderate to severe atopic dermatitis. Atopic dermatitis is also known as eczema. Cibinqo is useful for adults with

iStock 1252840886
Patient Content
DeLene Beeland

What Is Rinvoq® (upadacitinib)?

Rinvoq® (upadacitinib) is a drug for moderate to severe atopic dermatitis, or eczema. It is useful for people who are unable to take other medicines, therapies,

iStock 1374573261
Patient Content
DeLene Beeland

Susvimo® (ranibizumab)

Susvimo® (ranibizumab injection) is approved to treat people with wet age-related macular degeneration (AMD) who have previously responded to at least 2 anti-vascular endothelial growth factor

iStock 1217908833
Patient Content
DeLene Beeland

Vabysmo® (faricimab)

Vabysmo® (faricimab) is approved to treat people with wet age-related macular degeneration (AMD) who have previously responded to at least 2 injections of an endothelial growth